CTY: Greene Barry E reports a stock award
By AlphaYouPublished Form 4
Greene Barry E
Reporting filer
Greene Barry E reports a stock award, not an open-market purchase or sale, in City Therapeutics, Inc.. Form 4 filed Oct 19, 2026 lists 1 entry.
- Disclosed
- Oct 19, 2026
Reported details
1 entry| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) (derivative) | Greene Barry E | 2026-10-15 | A | Grant or award | 22649 | 0 | 22,649 | 4 days | Filed terms
|
Stock Option (Right to Buy) (derivative)
- Owner
- Greene Barry E
- Date
- 2026-10-15
- Code
- A
- Action
- Grant or award
- Quantity
- 22649
- Price
- 0
- Following holdings
- 22,649
- Reporting delay
- 4 days
- Filed terms and references
Filed terms
- security Title: Stock Option (Right to Buy)
- conversion Or Exercise Price: 18
- transaction Date: 2026-10-15
- deemed Execution Date:
- transaction Form Type: 4
- transaction Code: A
- equity Swap Involved: 0
- transaction Timeliness:
- transaction Shares: 22649
- transaction Price Per Share: 0
- transaction Acquired Disposed Code: A
- id: F1
- expiration Date: 2036-10-14
- underlying Security Title: Common Stock
- underlying Security Shares: 22649
- shares Owned Following Transaction: 22649
- direct Or Indirect Ownership: D
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Greene Barry E: Director.
- F1: The shares underlying this option vest in full upon the earlier of (i) October 15, 2027 or (ii) the date of the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service on such vesting date.
Original sources
Prepared automatically from public filing data. Report a correction.